EGFR Signaling Networks in Cancer Therapy - Couverture souple

Livre 56 sur 96: Cancer Drug Discovery and Development

9781617378539: EGFR Signaling Networks in Cancer Therapy

Couverture souple

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Editeur : Humana, 2011

Afficher les exemplaires de cette �dition comportant l?ISBN

0 D'occasion

10 Neuf

De EUR 182,29

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

Pr�sentation de l'�diteur

The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues. This volume probes and explores this fascinating system with compelling information.

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: Humana
Date d'�dition: 2011
Langue: anglais
ISBN 10: 1617378534
ISBN 13: 9781617378539
Reliure: Broch�
Nombre de pages: 412
�diteur: Haley John D., Gullick William John
Coordonn�es du fabricant: ProductSafety@springernature.com
ProductSafety@springernature.com

Poststr. 9
Darmstadt
64293
Allemagne

Autres �ditions populaires du m�me titre

9781588299482: EGFR Signaling Networks in Cancer Therapy

Edition pr�sent�e

ISBN 10 : 1588299481 ISBN 13 : 9781588299482
Editeur : Humana Press Inc., 2008
Couverture rigide

(Couverture souple)

R�sultats de recherche pour EGFR Signaling Networks in Cancer Therapy

Image d'archives

EGFR Signaling Networks in Cancer Therapy (eng)

Haley, John D.

Edit� par Humana, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Couverture souple

impression � la demande

Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie

�valuation du vendeur 4 sur 5 �toiles

Etat : new. Questo � un articolo print on demand. N� de r�f. du vendeur 24ZINSMO5D

Contacter le vendeur

Acheter neuf

EUR 182,29

Exp�dition �EUR 8
Exp�dition depuis Italie vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

EGFR Signaling Networks in Cancer Therapy

Haley, John D.|Gullick, William John

Edit� par Humana Press, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Kartoniert / Broschiert

impression � la demande

Vendeur : moluna, Greven, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Probes the molecular pathways and the intersection of signaling networks which are frequently deregulated in human cancersDescribes EGF receptor in a tumor tissue specific context Illustrates the many ways in which EGF receptors contribute . N� de r�f. du vendeur 4257015

Contacter le vendeur

Acheter neuf

EUR 192,60

Exp�dition �EUR 48,99
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

EGFR Signaling Networks in Cancer Therapy

William John Gullick

Edit� par Humana Press Jan 2011, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context. 408 pp. Englisch. N� de r�f. du vendeur 9781617378539

Contacter le vendeur

Acheter neuf

EUR 235,39

Exp�dition �EUR 23
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

EGFR Signaling Networks in Cancer Therapy

William John Gullick (u. a.)

Edit� par Humana Press, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Taschenbuch

Vendeur : preigu, Osnabr�ck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Contacter le vendeur

Acheter neuf

EUR 202,80

Exp�dition �EUR 70
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 5 disponible(s)

Ajouter au panier

Image fournie par le vendeur

EGFR Signaling Networks in Cancer Therapy

William John Gullick

Edit� par Humana Press, Humana Press Jan 2011, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 408 pp. Englisch. N� de r�f. du vendeur 9781617378539

Contacter le vendeur

Acheter neuf

EUR 235,39

Exp�dition �EUR 60
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

EGFR Signaling Networks in Cancer Therapy

William John Gullick

Edit� par Humana Press, Humana Press, 2011

ISBN 10 : 1617378534 ISBN 13 : 9781617378539

Neuf Taschenbuch

impression � la demande

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies. Over decades of study, the EGF receptor structure, its ligand binding domains, the physical biochemistry underlying its intrinsic tyrosine kinase catalytic function and the modular interactions with SH2, PTB, and SH3 domain containing signaling adaptor p- teins required for signal transduction, have been extensively dissected. Not only is the EGF receptor the nexus of many streams of information, but it also forms one part of a calcul- ing device by forming dimers and oligomers with the other three receptors in its family in response to at least eleven ligands (some of which are expressed in multiple forms with overlapping or quite distinct functions). This phenomenon, while recruiting to the inner surface of the cell membrane and activating multiple second messenger proteins, also allows the possibility of cross talk between these systems, permitting a further layer of information to be exchanged. Less well described are the cross re gulation of the EGF receptor and other anti-apoptotic, mitogenic and metabolic signaling systems. The study of these systems has yielded new surprises. One hurdle in these efforts has been that signal transduction pathways have frequently been defined in the generic absence of their tissue-specific or cell-interaction specific context. N� de r�f. du vendeur 9781617378539

Contacter le vendeur